GERN has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
|Insider||Position||Date||Buy/Sell||Shares||Shares Owned Following This||Trade Price ($)||Cost ($1000)||Price Change
Since Trade (%)
|SCARLETT JOHN A||President and CEO|
(Click for the stocks that their CEOs have bought)
|BEHRS MELISSA KELLY||SVP Alliance and Prog Mgmt||2013-01-17||Sell||28,292||0||$1.65||46.7||210.3||Link|
|BEHRS MELISSA KELLY||SVP Strategic Portfolio Mgmt||2012-05-30||Sell||18,910||405,151||$1.37||25.9||273.72||Link|
|Bloom Olivia Kyusuk||VP, Chief Acctg Officer||2012-05-30||Sell||11,029||147,782||$1.37||15.1||273.72||Link|
|EARP DAVID||SVP, Corp Transactions||2012-05-30||Sell||27,155||467,406||$1.37||37.2||273.72||Link|
|Kelsey Stephen Michael||EVP, R&D Head, CMO||2012-05-30||Sell||9,300||473,122||$1.37||12.7||273.72||Link|
|GREENWOOD DAVID||President, Interim CEO, CFO||2011-06-14||Sell||34,005||754,031||$4.28||145.5||19.63||Link|
|BEHRS MELISSA KELLY||SVP Strategic Portfolio Mgmt||2011-06-14||Sell||25,262||424,061||$4.28||108.1||19.63||Link|
|Kelsey Stephen Michael||EVP, R&D Head, CMO||2011-06-14||Sell||4,858||476,773||$4.28||20.8||19.63||Link|
|LEBKOWSKI JANE||SVP, Chief Scientific Officer||2011-06-14||Sell||25,262||568,154||$4.28||108.1||19.63||Link|
|Spink Katharine E.||SVP Alliance Mgmt & Operations||2011-06-14||Sell||22,591||328,561||$4.28||96.7||19.63||Link|
|Bloom Olivia Kyusuk||VP, Chief Acctg Officer||2011-06-14||Sell||6,997||158,811||$4.28||29.9||19.63||Link|
|EARP DAVID||Chief Legal Counsel||2011-06-14||Sell||25,262||494,561||$4.28||108.1||19.63||Link|
|GREENWOOD DAVID||President, Interim CEO, CFO||2011-05-24||Sell||4,462||788,036||$4.47||19.9||14.54||Link|
|LEBKOWSKI JANE||SVP, Chief Scientific Officer||2011-05-24||Sell||2,975||593,416||$4.47||13.3||14.54||Link|
|EARP DAVID||SVP Bus Dev, Chief Patnt Couns||2011-05-24||Sell||2,975||519,823||$4.47||13.3||14.54||Link|
|BEHRS MELISSA KELLY||SVP Strategic Portfolio Mgmt||2011-05-24||Sell||2,975||449,323||$4.47||13.3||14.54||Link|
|Spink Katharine E.||SVP Prgm Mgmt, Cell Therapies||2011-05-24||Sell||419||351,152||$4.47||1.9||14.54||Link|
|Bloom Olivia Kyusuk||VP, Chief Acctg Officer||2011-05-24||Sell||1,200||165,808||$4.47||5.4||14.54||Link|
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as Conversion of derivative security or Exercise of Options are not included. Insiders are only limited to Officers and/or Directors of the company.
Disclaimers: GuruFocus.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The gurus may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.